abrdn Life Sciences Investors (HQL) is a publicly traded Financial Services sector company. As of July 21, 2026, HQL trades at $19.75 with a market cap of $600.25M and a P/E ratio of 0.00. HQL moved +1.00% today. Year to date, HQL is +16.10%; over the trailing twelve months it is +44.74%. Its 52-week range spans $10.55 to $21.32. Rallies surfaces HQL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest HQL news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $19.75 |
| Market Cap | $600.25M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.56% |
| 52-Week High | $21.32 |
| 52-Week Low | $10.55 |
| Volume | 52.72K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
HQL analyst coverage data. Average price target: $0.00.